Literature DB >> 3264694

Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus.

M L Boey1, C L Peebles, G Tsay, P H Feng, E M Tan.   

Abstract

Serum samples from 94 patients with systemic lupus erythematosus (SLE) from a medical unit in Singapore were analysed for autoantibodies of 10 different specificities. The prevalence of antibodies to the following antigens was as follows: double stranded (ds) DNA (43%), histone (81%), Sm (26%), nuclear ribonuclear protein (nRNP) (32%), SS-A(Ro) (63%), SS-B(La) (12%), SL/Ki (9%), ribosomal RNP (rRNP) (16%), p70/p80 (5%), proliferating cell nuclear antigen (PCNA) (3%). Except for a higher prevalence of anti-SS-A(Ro), other autoantibodies were within the range reported from Western countries, indicating a high uniformity of autoantibody profiles in SLE in different countries. Patients with neuropsychiatric manifestations showed a higher plurality of antibodies per patient than patients without neuropsychiatric symptoms, 4.22 v 2.77. Patients with anti-Sm were more likely to have active lupus disease. There was no increased prevalence or specific type of autoantibody in those with renal manifestations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264694      PMCID: PMC1003633          DOI: 10.1136/ard.47.11.918

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Epitopes, structural domains, and asymmetry of amino acid residues in SS-B/La nuclear protein.

Authors:  E K Chan; A M Francoeur; E M Tan
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

2.  An immunoassay differentiating sera with antibodies to Sm alone, antibodies to Sm/RNP complex, and antibodies to RNP alone.

Authors:  G J Tsay; E K Chan; C L Peebles; K M Pollard; E M Tan
Journal:  Arthritis Rheum       Date:  1987-04

3.  Application, to Japanese patients, of the 1982 American Rheumatism Association revised criteria for the classification of systemic lupus erythematosus.

Authors:  R Yokohari; T Tsunematsu
Journal:  Arthritis Rheum       Date:  1985-06

Review 4.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

5.  Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies.

Authors:  K Ogata; Y Ogata; R M Nakamura; E M Tan
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

6.  Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody.

Authors:  K M Pollard; E M Tan
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus.

Authors:  R D Sontheimer; P J Maddison; M Reichlin; R E Jordon; P Stastny; J N Gilliam
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

9.  Systemic lupus erythematosus in Chinese: the Singapore experience.

Authors:  P H Feng; M L Boey
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

10.  Interaction between VA RNA and the lupus antigen La: formation of a ribonucleoprotein particle in vitro.

Authors:  A M Francoeur; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

View more
  21 in total

1.  Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus.

Authors:  Sung Soo Ahn; Seung Min Jung; Juyoung Yoo; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park
Journal:  Rheumatol Int       Date:  2019-09-24       Impact factor: 2.631

Review 2.  Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus.

Authors:  G Q Shen; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.

Authors:  Mariangelí Arroyo-Ávila; Yesenia Santiago-Casas; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Luis M Vilá; Elizabeth E Brown
Journal:  Clin Rheumatol       Date:  2015-04-22       Impact factor: 2.980

Review 4.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

Review 5.  Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.

Authors:  A J Swaak; V Huysen; J C Nossent; R J Smeenk
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 6.  Lupus Nephritis in Asia: Clinical Features and Management.

Authors:  Desmond Y H Yap; Tak Mao Chan
Journal:  Kidney Dis (Basel)       Date:  2015-08-05

7.  Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features.

Authors:  M G Cohen; K M Pollard; J Webb
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

8.  The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.

Authors:  R W Burlingame; M L Boey; G Starkebaum; R L Rubin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population.

Authors:  Lian Hong Li; Hai Feng Pan; Wen Xian Li; Xiang Pei Li; Jian Hua Xu; Dong Qing Ye
Journal:  Clin Rheumatol       Date:  2009-08-07       Impact factor: 2.980

10.  Changes in clinical features of patients with systemic lupus erythematosus followed prospectively over 2 decades.

Authors:  A J Swaak; E J Nieuwenhuis; R J Smeenk
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.